$100MRound, 10 November 2025
Raised over $100M in an oversubscribed round to advance clinical programs KIF18A and CDK2/4.
- Amount
- $100M
- Announced
- 10 November 2025
- Lead
- Abingworth
- Other investors
- Alexandria Venture Investments, Alumni Ventures, ARK, Catalio, Illumina Ventures, Mubadala, Qatar Investment Authority, Regeneron Ventures, Sequoia
- Use of funds
- Raised over $100M in an oversubscribed round to advance clinical programs KIF18A and CDK2/4.
- Checked
- Announced by the company
- Sources
- Iambic secures $100M for drug discovery platform - MobiHealthNews businesswire.com
Iambic secures $100M for drug discovery platform - MobiHealthNews MobiHealthNews